Brief: Guardant Health And Collaborators To Present New Data Across The Cancer Care Continuum At Esmo 2025
15/10/2025 23:18
Guardant Health Inc GH.O: GUARDANT HEALTH AND COLLABORATORS TO PRESENT NEW DATA ACROSS THE CANCER CARE CONTINUUM AT ESMO 2025 Source text: ID:nBw1cGHbga Further company coverage: GH.O
Recent news on Guardant Health
See all newsBrief: Guardant Health Announces Approval In Europe Of Guardant360® Cdx
Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms
US Health Secretary Kennedy Jr. adds eight new members to key health committee (updated)
Brief: US FDA Grants Accelerated Approval To Etcamah For Advanced Breast Cancer With ESR1 Mutation
Brief: Guardant Health To Appeal Federal District Court Judgment